2021 Nelson's Pediatric Antimicrobial Therapy-27판

Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest
recommendations for treatment of infectious diseases in children, including COVID-19. For each disease, the authors
provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial
agents available today and include complete information about dosing regimens. New in the 27th edition: Continuous
updates of drug and dosing changes available online at aap.org/Nelsons 4 new chapters Reorganized chapter order to
improve functionality


Introduction
Ch 1. Antimicrobial Therapy According to Clinical Syndromes
A. Skin and Soft Tissue Infections
B. Skeletal Infections
C. Eye Infections
D. Ear and Sinus Infections
E. Oropharyngeal Infections
F. Lower Respiratory Tract Infections
G. Cardiovascular Infections
H. Gastrointestinal Infections
I. Genital and Sexually Transmitted Infections
J. Central Nervous System Infections
K. Urinary Tract Infections
L. Miscellaneous Systemic Infections
Ch 2. Antimicrobial Therapy for Neonates
A. Recommended Therapy for Selected Neonatal Conditions
B. Antimicrobial Dosages for Neonates
C. Aminoglycosides
D. Vancomycin
E. Use of Antimicrobials During Pregnancy or Breastfeeding
Ch 3. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
A. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
B. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
C. Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
D. Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
Ch 4. Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macroli
Ch 5. Preferred Therapy for Specific Fungal Pathogens
A. Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
B. Systemic Infections
C. Localized Mucocutaneous Infections
Ch 6. Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
Ch 7. Preferred Therapy for Specific Viral Pathogens
A. Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to
B. Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
C. Preferred Therapy for Specific Viral Pathogens
Ch 8. Choosing Among Antiviral Agents
Ch 9. Preferred Therapy for Specific Parasitic Pathogens
A. Selected Common Pathogenic Parasites and Suggested Agents for Treatment
B. Preferred Therapy for Specific Parasitic Pathogens
Ch 10. Choosing Among Antiparasitic Agents: Antimalarial Drugs, Nitroimidazoles, Benzimidazoles, and
Ch 11. How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatm
Ch 12. Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and Methicillin-Resis
Ch 13. Antibiotic Therapy for Children Who Are Obese
Ch 14. Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
Ch 15. Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
A. Postexposure Antimicrobial Prophylaxis to Prevent Infection
B. Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
C. Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
D. Surgical/Procedure Prophylaxis
Ch 16. Approach to Antibiotic Allergies
Ch 17. Antibiotic Stewardship
Ch 18. Alphabetic Listing of Antimicrobials
A. Systemic Antimicrobials With Dosage Forms and Usual Dosages
B. Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
Appendix: Nomogram for Determining Body Surface Area
References
Index